Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-09 11:32 am Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | VANGUARD GROUP INC | 4,186,542 5.32% | 885,404 (+26.82%) | View |
| 2023-02-06 2:56 pm Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | WELLINGTON MANAGEMENT GROUP LLP | 3,507,017 4.45% | 16,138 (+0.46%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | BlackRock Inc. BLK | 5,587,535 7.1% | 2,248,066 (+67.32%) | View |
| 2023-01-31 10:47 am Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | STATE STREET CORP STT | 3,978,985 5.05% | 3,978,985 (New Position) | View |
| 2022-10-11 4:30 pm Purchase | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 17,628,567 24.4% | 1,355,932 (+8.33%) | View |
| 2022-09-21 09:00 am Unchanged | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 16,272,635 24.6% | 0 (Unchanged) | View |
| 2022-02-14 5:18 pm Sale | 13G | Rocket Pharmaceuticals, Inc. RCKT | PERCEPTIVE ADVISORS LLC | 1,959,125 3% | -1,437,742 (-42.33%) | View |
| 2022-02-14 4:00 pm Sale | 13G | Rocket Pharmaceuticals, Inc. RCKT | TANG CAPITAL PARTNERS LP | 2,531,800 3.9% | -433,685 (-14.62%) | View |
| 2022-02-14 2:34 pm Sale | 13G | Rocket Pharmaceuticals, Inc. RCKT | PRICE T ROWE ASSOCIATES INC | 2,192,894 3.4% | -1,286,427 (-36.97%) | View |
| 2022-02-10 08:37 am Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | VANGUARD GROUP INC | 3,301,138 5.12% | 3,301,138 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | BlackRock Inc. BLK | 3,339,469 5.2% | 2,307,398 (+223.57%) | View |
| 2022-02-04 09:22 am Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | WELLINGTON MANAGEMENT GROUP LLP | 3,490,879 5.42% | 3,490,879 (New Position) | View |
| 2021-08-31 5:08 pm Purchase | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 16,272,635 25.3% | 87,516 (+0.54%) | View |
| 2021-03-29 5:19 pm Sale | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 16,185,119 26.2% | -1,344,925 (-7.67%) | View |
| 2021-02-16 3:45 pm Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | PERCEPTIVE ADVISORS LLC | 3,396,867 5.6% | 3,396,867 (New Position) | View |
| 2021-02-16 12:23 pm Purchase | 13G | Rocket Pharmaceuticals, Inc. RCKT | PRICE T ROWE ASSOCIATES INC | 3,479,321 5.7% | 3,479,321 (New Position) | View |
| 2021-01-08 3:30 pm Purchase | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 17,530,044 29.3% | 247,720 (+1.43%) | View |
| 2020-02-14 4:47 pm Sale | 13G | Rocket Pharmaceuticals, Inc. RCKT | Boxer Capital LLC | 1,466,051 2.7% | -500,000 (-25.43%) | View |
| 2020-02-12 4:25 pm Sale | 13G | Rocket Pharmaceuticals, Inc. RCKT | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -2,400,000 (Position Closed) | View |
| 2019-12-13 4:00 pm Purchase | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 17,282,324 31.9% | 225,000 (+1.32%) | View |